CE · Celanese Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBIT non-GAAP | $470M | Three Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net earnings (loss) attributable to Celanese Corporation $125M
+$2M (Earnings) loss from discontinued operations
-$10M Interest income
+$186M Interest expense
+$0M Refinancing expense
+$11M Income tax provision (benefit)
+$156M Certain Items attributable to Celanese Corporation (Table 8)
= Adjusted EBIT $470M
|
|||
| Adjusted EBIT - Acetyl Chain non-GAAP | $321M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBIT - Engineered Materials non-GAAP | $234M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBIT margin non-GAAP | 17.1% | Q2 '26 | — |
| Free cash flow non-GAAP | $140M | Three Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net cash provided by (used in) operating activities 209M
-62M Capital expenditures on property, plant and equipment
-7M Contributions from/(Distributions) to NCI
= Free cash flow 140M
|
|||
| Free cash flow as % of Net sales non-GAAP | 5.1% | Q2 '26 | — |
|
|
|||
| Operating EBITDA non-GAAP | $649M | Three Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Adjusted EBIT $470M
+$179M Depreciation and amortization expense
= Operating EBITDA $649M
|
|||
| Operating EBITDA margin non-GAAP | 23.6% | Q2 '26 | — |
| Return on invested capital (adjusted) non-GAAP | 6.2% | 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CE
this stock
Celanese Corp
|
$4.90B | +9.4% | -7.1% | — | 7.8% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$76.69B | +23.6% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$23.07B | +35.8% | -7.0% | — | 4.9% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.43B | +21.7% | — | — | 0.0% |
|
MEOH
Methanex Corp
|
$4.43B | +42.5% | — | — | 2.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CE | +6.8% | -4.3% | -5.8% | +3.4% | +9.4% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +7.3% | -7.2% | -17.4% | +0.5% | -3.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.